Al-Hussein University Hospital & Sayed Galal University Hospital
Cairo, Cairo Governorate, Egypt
Location status: Recruiting
NCT Number: NCT07693595
The goal of this observational study is to evaluate nailfold capillaroscopic changes in patients with psoriasis and to assess their correlation with disease severity. The study will also explore differences in capillaroscopic findings across different clinical types of psoriasis and skin phototypes (Fitzpatrick classification). The study will include patients diagnosed with psoriasis attending dermatology outpatient clinics. Participants will undergo clinical assessment and nailfold capillaroscopy to detect microvascular changes.
Interested in participating?
Request InfoAll sexes
Observational
Cairo, Cairo Governorate, Egypt
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will undergo nailfold capillaroscopy using a USB digital capillaroscope to assess microvascular changes in psoriatic patients. Clinical assessment including PASI score and evaluation of nail involvement will also be performed.
Other names: Dermoscopy (if used for nails)
Time frame: Baseline
Detection and description of nailfold capillaroscopic (NFC) abnormalities in patients with psoriasis.
Time frame: Baseline
Correlation between PASI score and presence of NFC changes.
Contact information is provided by the study sponsor or research team.
Ahmed H Nouh, Asst Prof Derm & Venereol
CONTACT
Hadil J Albarrawi
CONTACT
Al-Azhar University
Other
Nailfold Capillaroscopic Changes in Psoriasis and Its Correlation With Disease Severity
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07736651
Inflammation, Pathologic Processes
Giza, Ad Doki, Egypt
View Trial DetailsNCT04864886
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Bethesda, Maryland, United States
View Trial DetailsNCT04170244
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Rochester, New York, United States
View Trial DetailsNCT07489885
Psoriasis, Skin Diseases
Birmingham, Alabama, United States
View Trial Details